• About
  • Products
  • News
  • Investor
    • Corporate
    • Financial
    • Stock
  • Contact

PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023

by PanGenomic | August 30, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments

by PanGenomic | July 7, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Provides Update for NARA Product and Conversational AI

by PanGenomic | June 6, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform

by PanGenomic | May 30, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Announces Financial Results for the 2022 Fiscal Year

by PanGenomic | May 3, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants

by PanGenomic | April 21, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Admitted to Trading on the AQSE Growth Market in London, United Kingdom

by PanGenomic | April 12, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Retains UK Investor Relations Advisory Firm

by PanGenomic | April 6, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System

by PanGenomic | March 30, 2023 | Business Update | 0 Comments

Read More

PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing

by PanGenomic | March 28, 2023 | Business Update | 0 Comments

Read More
Business Update

PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023

PanGenomic
Aug 30, 2023
Business Update

PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments

PanGenomic
Jul 07, 2023
Business Update

PanGenomic Health Provides Update for NARA Product and Conversational AI

PanGenomic
Jun 06, 2023
Business Update

PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform

PanGenomic
May 30, 2023
Business Update

PanGenomic Health Announces Financial Results for the 2022 Fiscal Year

PanGenomic
May 03, 2023
Business Update

PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants

PanGenomic
Apr 21, 2023
Business Update

PanGenomic Health Admitted to Trading on the AQSE Growth Market in London, United Kingdom

PanGenomic
Apr 12, 2023
Business Update

PanGenomic Health Retains UK Investor Relations Advisory Firm

PanGenomic
Apr 06, 2023
Business Update

PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System

PanGenomic
Mar 30, 2023
Business Update

PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing

PanGenomic
Mar 28, 2023
Business Update

Circle Innovation to Support PanGenomic Health Subsidiary, MUJN Diagnostics, with the Development of its Decision Support System

PanGenomic
Mar 22, 2023
Business Update

PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report

PanGenomic
Mar 09, 2023
Business Update

PanGenomic Health Provides Corporate Update

PanGenomic
Mar 02, 2023
Business Update

PanGenomic Health’s NARA Debuts New Website, Visual Identity & Natural Wellness E-Commerce Store

PanGenomic
Feb 09, 2023
Business Update

PanGenomic Health Subsidiary Signs Rental Agreement with Psy Integrated Health, Makes Progress Towards Development of Joint Testing Facility

PanGenomic
Feb 02, 2023
Business Update

PanGenomic Health Announces Intention to Dual List on the UK Aquis Stock Exchange Growth Market

PanGenomic
Jan 31, 2023
Business Update

Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc.

PanGenomic
Jan 30, 2023
Business Update

PanGenomic Health Subsidiary Signs Non-Binding MoU with Psy Integrated Health for Diagnostic Testing Joint Venture

PanGenomic
Jan 23, 2023
Business Update

PanGenomic Health’s Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs

PanGenomic
Jan 23, 2023
Business Update

PanGenomic Health Announces Soft Launch of NARA Personalized DNA Reports and Closing of its Non-Brokered Private Placement Offering

PanGenomic
Jan 20, 2023
Business Update

PanGenomic Health’s Mindleap App to Expand

PanGenomic
Jan 16, 2023
Business Update

PanGenomic Health Subsidiary Signs Partnership with LumiQuick Diagnostics

PanGenomic
Jan 12, 2023
Business Update

PanGenomic Health to Launch E-Commerce Platform for Personalized Natural Health

PanGenomic
Jan 09, 2023
Business Update

PanGenomic Health Retains Capital Markets Advisory Firm

PanGenomic
Jan 03, 2023
Business Update

PanGenomic Health Announces Non-Brokered Private Placement Offering and Closing of First Tranche under Offering

PanGenomic
Dec 24, 2022
Business Update

Year End Letter to Our Shareholders

PanGenomic
Dec 22, 2022
Business Update

PanGenomic Health Enters into Definitive Agreement for Acquisition of Mindleap Health

PanGenomic
Nov 21, 2022
Business Update

PanGenomic Health Appoints Maryam Marissen as CEO

PanGenomic
Sep 07, 2022
Business Update

PanGenomic Health Inc. Signs a Non-binding Letter of Intent for the Acquisition of Mindleap Health Inc.

PanGenomic
Sep 01, 2022
Business Update

Natural Remedy App Launched to Support Mental Health

PanGenomic
Aug 03, 2022
Business Update

PanGenomic Health engages Investor Relations Services Provider, Meus Management, and Market Maker Services Provider, Generation IACP

PanGenomic
Jul 20, 2022
Business Update

PanGenomic Health Inc. Acquires Behavioural Nudge Technology

PanGenomic
Mar 21, 2022
Business Update

PanGenomic Health Launches Mental Health App

PanGenomic
Mar 16, 2022
  • Follow
  • Follow
  • Follow
  • Follow

GET IN TOUCH

info@pangenomic.com

ABOUT US

Privacy Policy

Our Story

NEWSLETTER

Contact Us

© 2023 PanGenomic Health Inc.
A public benefit company.

Manage Cookie Consent
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}